FORA Capital
BIOA icon

FORA Capital’s BioAge Labs BIOA Stock Holding History

FORA Capital’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$83.8K Buy
+11,855
New +$164K ﹤0.01% 602

Other funds holding BIOA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Sands Capital Ventures
Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return
Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor San Francisco, California $252M AUM 45.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
CM
Cosmic Management West Hollywood, California $327M AUM 21.97% 1-Year Est. Return

FORA Capital's BIOA Position: Q3 2026 in Review

FORA Capital opened a new position in BioAge Labs (BIOA) in Q3 2026: 11,855 shares worth $83.8K. The stake represents ﹤0.01% of the portfolio and ranks #602 among its holdings.

104 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • FORA Capital held 11,855 shares of BioAge Labs worth $83.8K as of Q3 2026.
  • BioAge Labs was a new FORA Capital position in Q3 2026.
  • BioAge Labs made up ﹤0.01% of FORA Capital's portfolio in Q3 2026, its #602 holding.
  • 104 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on FORA Capital's 13F filing for Q3 2026, filed 13 Nov 2026.